Pal SK - Search Results

1

Learning from BISCAY: The future of biomarker-based trial design in bladder cancer.

Meza L, Salgia NJ, Patel KC, Pal SK. Meza L, et al. Among authors: pal sk. Cancer Cell. 2021 Jul 12;39(7):910-912. doi: 10.1016/j.ccell.2021.06.011. Cancer Cell. 2021. PMID: 34256907 Free article.

2

The role of targeting mammalian target of rapamycin in lung cancer.

Pal SK, Figlin RA, Reckamp KL. Pal SK, et al. Clin Lung Cancer. 2008 Nov;9(6):340-5. doi: 10.3816/CLC.2008.n.049. Clin Lung Cancer. 2008. PMID: 19073516 Review.

3

Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers.

Pal SK, Kortylewski M, Yu H, Figlin RA. Pal SK, et al. Mol Cancer Ther. 2010 Dec;9(12):3115-25. doi: 10.1158/1535-7163.MCT-10-0873. Epub 2010 Nov 15. Mol Cancer Ther. 2010. PMID: 21078774 Free PMC article. Review.

4

Clinical outcome in patients receiving systemic therapy for metastatic sarcomatoid renal cell carcinoma: a retrospective analysis.

Pal SK, Jones JO, Carmichael C, Saikia J, Hsu J, Liu X, Figlin RA, Twardowski P, Lau C. Pal SK, et al. Urol Oncol. 2013 Nov;31(8):1826-31. doi: 10.1016/j.urolonc.2012.04.007. Epub 2012 May 17. Urol Oncol. 2013. PMID: 22608544 Free PMC article.

5

S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.

Deng J, Liu Y, Lee H, Herrmann A, Zhang W, Zhang C, Shen S, Priceman SJ, Kujawski M, Pal SK, Raubitschek A, Hoon DSB, Forman S, Figlin RA, Liu J, Jove R, Yu H. Deng J, et al. Among authors: pal sk. Cancer Cell. 2012 May 15;21(5):642-654. doi: 10.1016/j.ccr.2012.03.039. Cancer Cell. 2012. PMID: 22624714 Free PMC article.

6

Retrospective analysis of clinical outcomes with neoadjuvant cisplatin-based regimens for muscle-invasive bladder cancer.

Pal SK, Ruel NH, Wilson TG, Yuh BE. Pal SK, et al. Clin Genitourin Cancer. 2012 Dec;10(4):246-50. doi: 10.1016/j.clgc.2012.08.004. Epub 2012 Sep 13. Clin Genitourin Cancer. 2012. PMID: 22981208 Free PMC article.

7

Differentiating mTOR inhibitors in renal cell carcinoma.

Pal SK, Quinn DI. Pal SK, et al. Cancer Treat Rev. 2013 Nov;39(7):709-19. doi: 10.1016/j.ctrv.2012.12.015. Epub 2013 Feb 21. Cancer Treat Rev. 2013. PMID: 23433636 Free PMC article. Review.

8

Bladder cancer.

Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho M; National Comprehensive Cancer Network (NCCN). Clark PE, et al. Among authors: pal sk. J Natl Compr Canc Netw. 2013 Apr 1;11(4):446-75. doi: 10.6004/jnccn.2013.0059. J Natl Compr Canc Netw. 2013. PMID: 23584347

9

Optimizing systemic therapy for bladder cancer.

Pal SK, Milowsky MI, Plimack ER. Pal SK, et al. J Natl Compr Canc Netw. 2013 Jul;11(7):793-804. doi: 10.6004/jnccn.2013.0101. J Natl Compr Canc Netw. 2013. PMID: 23847217 Review.

10

A new age for vaccine therapy in renal cell carcinoma.

Pal SK, Hu A, Figlin RA. Pal SK, et al. Cancer J. 2013 Jul-Aug;19(4):365-70. doi: 10.1097/PPO.0b013e31829d74b4. Cancer J. 2013. PMID: 23867519 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,102 results

Search Page